Carfilzomib in Refractory Renal Cell Carcinoma (RCC)
Sponsors and Collaborators
M.D. Anderson Cancer Center
Onyx Therapeutics, Inc.
Eric Jonasch, MD
Eric Jonasch, MD, UT MD Anderson Cancer Center
Next post in Renal Cell Carcinoma Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.